Neema M, Goldberg-Zimring D, Guss ZD, Healy BC, Guttmann CR, Houtchens MK, Weiner HL, Horsfield MA, Hackney DB, Alsop DC, Bakshi R
3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage. 2009 Jul 01; 46(3):633-41.
3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.
A case for gender-based approach to multiple sclerosis therapeutics. Front Neuroendocrinol. 2018 07; 50:123-134.
A case for gender-based approach to multiple sclerosis therapeutics.
Khalid F, Healy BC, Dupuy SL, Chu R, Chitnis T, Bakshi R, Houtchens M
Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis. J Neurol Sci. 2018 09 15; 392:94-99.
Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
It is time to conduct phase 3 clinical trials of sex hormones in MS - No. Mult Scler. 2018 10; 24(11):1415-1417.
It is time to conduct phase 3 clinical trials of sex hormones in MS - No.
Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, Buckle G, Houtchens M, Stazzone L, Moodie J, Berger AM, Duan Y, Bakshi R, Khoury S, Weiner H, Ascherio A
Smoking and disease progression in multiple sclerosis. Arch Neurol. 2009 Jul; 66(7):858-64.
Smoking and disease progression in multiple sclerosis.
Cohen AB, Neema M, Arora A, Dell'oglio E, Benedict RH, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Ceccarelli A, Klein JP, Stankiewicz JM, Houtchens MK, Buckle GJ, Alsop DC, Guttmann CR, Bakshi R
Journal of neuroimaging : official journal of the American Society of Neuroimaging
The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2012 Apr; 22(2):122-8.
The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.
Healy BC, Liguori M, Tran D, Chitnis T, Glanz B, Wolfish C, Gauthier S, Buckle G, Houtchens M, Stazzone L, Khoury S, Hartzmann R, Fernandez-Vina M, Hafler DA, Weiner HL, Guttmann CR, De Jager PL
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology. 2010 Aug 17; 75(7):634-40.
HLA B*44: protective effects in MS susceptibility and MRI outcome measures.
International journal of obstetric anesthesia
Anesthetic management of a parturient with neuromyelitis optica. Int J Obstet Anesth. 2012 Oct; 21(4):371-5.
Anesthetic management of a parturient with neuromyelitis optica.
Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS. Neurology. 2018 10 23; 91(17):e1570-e1578.
Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS.
Houtchens MK, Edwards NC, Schneider G, Stern K, Phillips AL
Pregnancy rates and outcomes in women with and without MS in the United States. Neurology. 2018 10 23; 91(17):e1559-e1569.
Pregnancy rates and outcomes in women with and without MS in the United States.
Houtchens MK, Richert JR, Sami A, Rose JW
Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler. 1997 Aug; 3(4):250-3.
Open label gabapentin treatment for pain in multiple sclerosis.
Kaplan TB, Bove R, Galetta K, Healy B, Chitnis C, Houtchens M
Effect of pregnancy loss on MS disease activity. J Neurol Sci. 2019 Feb 15; 397:58-60.
Effect of pregnancy loss on MS disease activity.
Coyle PK, Oh J, Magyari M, Oreja-Guevara C, Houtchens M
Multiple sclerosis and related disorders
Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Mult Scler Relat Disord. 2019 Jul; 32:54-63.
Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review.
Corresponding Member of the Faculty of Neurology
Jack, Sadie and David Breakstone Professor of Neurology
Sadovnick AD, Carruthers R, Houtchens M, Schabas A, Smyth P
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS): Rationale and Methodology. Can J Neurol Sci. 2020 Jan; 47(1):109-114.
Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS): Rationale and Methodology.
Zurawski J, Healy BC, Ratajska A, Barker L, Glanz BI, Houtchens M
Identification of a predominant cognitive phenotype in patients with multiple sclerosis. Eur J Neurol. 2020 06; 27(6):1083-1088.
Identification of a predominant cognitive phenotype in patients with multiple sclerosis.
Mahlanza TD, Manieri MC, Klawiter EC, Solomon AJ, Lathi E, Ionete C, Berriosmorales I, Severson C, Stankiewicz J, Cabot A, Elkort M, Chitnis T, Bove R, Katz J, Houtchens M
Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis. Mult Scler. 2021 01; 27(1):79-89.
Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis.
Maghzi AH, Houtchens MK, Preziosa P, Ionete C, Beretich BD, Stankiewicz JM, Tauhid S, Cabot A, Berriosmorales I, Schwartz THW, Sloane JA, Freedman MS, Filippi M, Weiner HL, Bakshi R
COVID-19 in teriflunomide-treated patients with multiple sclerosis. J Neurol. 2020 Oct; 267(10):2790-2796.
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K
Therapeutic advances in neurological disorders
Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord. 2020; 13:1756286420936166.
Sex effects across the lifespan in women with multiple sclerosis.
Houtchens M, Bove R, Healy B, Houtchens S, Kaplan TB, Mahlanza T, Chitnis T, Bakshi R
Neurology(R) neuroimmunology & neuroinflammation
MRI activity in MS and completed pregnancy: Data from a tertiary academic center. Neurol Neuroimmunol Neuroinflamm. 2020 11 05; 7(6).
MRI activity in MS and completed pregnancy: Data from a tertiary academic center.
Houtchens MK, Edwards NC, Hayward B, Mahony MC, Phillips AL
Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database. Mult Scler Relat Disord. 2020 Nov; 46:102541.
Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database.
Anderson A, Krysko KM, Rutatangwa A, Krishnakumar T, Chen C, Rowles W, Zhao C, Houtchens MK, Bove R
Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS. Neurol Neuroimmunol Neuroinflamm. 2021 03; 8(2).
Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS.
Khayat-Khoei M, Conway S, Rubinson DA, Jarolim P, Houtchens MK
Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab. J Neurol. 2021 Oct; 268(10):3592-3594.
Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab.
Bove R, Okai A, Houtchens M, Elias-Hamp B, Lugaresi A, Hellwig K, Kubala Havrdová E
Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review. Front Neurol. 2021; 12:554375.
Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review.
Haddad NR, Caplan R, Houtchens MK, Lyndon S
The Journal of neuropsychiatry and clinical neurosciences
Delayed-Onset Poststroke Psychosis Presenting as Delusional Disorder. J Neuropsychiatry Clin Neurosci. 2021 Fall; 33(4):342-344.
Delayed-Onset Poststroke Psychosis Presenting as Delusional Disorder.
Money KM, Mahatoo A, Samaan S, Anand P, Baber U, Bailey M, Bakshi R, Bouley A, Bower A, Cahill J, Houtchens M, Katz J, Lathi E, Levit E, Longbrake EE, McAdams M, Napoli S, Raibagkar P, Wade P, Sloane JA
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.
Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R
COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. 2022 Mar; 269(3):1093-1106.
COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
Krysko KM, Anderson A, Singh J, McPolin K, Rutatangwa A, Rowles W, Sadovnick AD, Houtchens MK, Bove R
Risk factors for peripartum depression in women with multiple sclerosis. Mult Scler. 2022 05; 28(6):970-979.
Risk factors for peripartum depression in women with multiple sclerosis.
Hellwig K, Rog D, McGuigan C, Houtchens MK, Bruen DR, Mokliatchouk O, Branco F, Peng X, Everage NJ
Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry. Neurol Neuroimmunol Neuroinflamm. 2022 01; 9(1).
Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry.
Pregnancy Management in Multiple Sclerosis and Other Demyelinating Diseases. Continuum (Minneap Minn). 2022 02 01; 28(1):12-33.
Pregnancy Management in Multiple Sclerosis and Other Demyelinating Diseases.
Houtchens M, Mahlanza T, Ciplea AI, Manieri MC, Ramia NF, Zhao Y, England S, Avila R, Altincatal A, Vignos M, Hellwig K
Peginterferon beta-1a concentrations in breast milk of lactating multiple sclerosis patients. Mult Scler Relat Disord. 2022 Apr; 60:103700.
Peginterferon beta-1a concentrations in breast milk of lactating multiple sclerosis patients.
Ostrem BL, Anderson A, Conway S, Healy BC, Oh J, Jacobs D, Dobson R, Graham EL, Sadovnick AD, Zimmerman V, Liu Y, Bove R, Houtchens M
Multiple sclerosis journal - experimental, translational and clinical
Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. Mult Scler J Exp Transl Clin. 2022 Apr-Jun; 8(2):20552173221104918.
Peripartum disease activity in moderately and severely disabled women with multiple sclerosis.
Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Mult Scler Relat Disord. 2022 Jul; 63:103946.
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders.
Pol-Patil J, Glanz B, Safar L, Misasi E, Manieri MC, Shanahan R, Healy B, Houtchens M
MeTooMS: Sexual, physical, and emotional abuse experience among women with multiple sclerosis. Mult Scler. 2023 02; 29(2):287-294.
MeTooMS: Sexual, physical, and emotional abuse experience among women with multiple sclerosis.
Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Mult Scler Relat Disord. 2022 Nov; 67:104079.
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.
Graham EL, Bakkensen JB, Anderson A, Lancki N, Davidson A, Perez Giraldo G, Jungheim ES, Vanderhoff AC, Ostrem B, Mok-Lin E, Huang D, Bevan CJ, Jacobs D, Kaplan TB, Houtchens MK, Bove R
Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era. Neurol Neuroimmunol Neuroinflamm. 2023 05; 10(3).
Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era.
Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M, Jokubaitis VG, Magyari M, Abdelnasser A, Padma V, Thiel S, Tintore M, Vukusic S, Hellwig K
Family planning considerations in people with multiple sclerosis. Lancet Neurol. 2023 04; 22(4):350-366.
Family planning considerations in people with multiple sclerosis.
Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T
No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. BMC Neurol. 2013 Jul 03; 13:73.
No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.
Conway S, Saxena S, Baecher-Allan C, Krishnan R, Houtchens M, Glanz B, Saraceno TJ, Polgar-Turcsanyi M, Bose G, Bakshi R, Bhattacharyya S, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Paul A, Weiner HL, Healy BC, Chitnis T
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine. Mult Scler J Exp Transl Clin. 2023 Apr-Jun; 9(2):20552173231165196.
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.
Hellwig K, Rog D, McGuigan C, Houtchens MK, Bruen DR, Mokliatchouk O, Branco F, Levin S, Everage N, Lin X
Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry. Mult Scler. 2024 Feb; 30(2):209-215.
Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.
Ocrelizumab in highly disabled progressive multiple sclerosis patients. Mult Scler Relat Disord. 2024 Feb; 82:105345.
Ocrelizumab in highly disabled progressive multiple sclerosis patients.
Radzik AM, Amezcua L, Anderson A, Gilmore S, Ahmad S, Brandstadter R, Fabian MT, Graham EL, Hodgkinson S, Horton L, Jacobs DA, Katz Sand IB, Kohli A, Levine L, McLemore M, Okai AF, Patel J, Poole S, Riley C, Satyanarayan S, Tardo L, Verter E, Villacorta V, Zimmerman V, Zuroff L, Williams MJ, Houtchens MK, Bove R
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort Neurology. 2024 02 27; 102(4):e208100.
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort
Jones RR, Turkoz I, Ait-Tihyaty M, DiBernardo A, Houtchens MK, Havrdová EK
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study. J Womens Health (Larchmt). 2024 04; 33(4):480-490.
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.
Hillert J, Bove R, Haddad LB, Hellwig K, Houtchens M, Magyari M, Merki-Feld GS, Montgomery S, Nappi RE, Stenager E, Thompson H, Tulek Z, Verdun Di Cantogno E, Simoni M
Expert opinion on the use of contraception in people with multiple sclerosis. Mult Scler. 2024 Aug; 30(9):1093-1106.
Expert opinion on the use of contraception in people with multiple sclerosis.
Pregnancy and reproductive health in women with multiple sclerosis: an update. Curr Opin Neurol. 2024 06 01; 37(3):202-211.
Pregnancy and reproductive health in women with multiple sclerosis: an update.
Graham EL, Bove R, Costello K, Crayton H, Jacobs DA, Shah S, Sorrell F, Stoll SS, Houtchens MK
Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths. Neurol Clin Pract. 2024 Apr; 14(2):e200253.
Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths.
Conway S, Gupta S, Healy B, Chuang TY, Stazzone L, Sullivan J, Polgar-Turcsanyi M, Chitnis T, Houtchens M
Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapies. Mult Scler Relat Disord. 2024 Jul; 87:105680.
Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapies.
Multiple sclerosis and pregnancy: therapeutic considerations. J Neurol. 2013 May; 260(5):1202-14.
Multiple sclerosis and pregnancy: therapeutic considerations.
Multiple sclerosis and pregnancy. Clin Obstet Gynecol. 2013 Jun; 56(2):342-9.
Merki-Feld GS, Bove R, Haddad LB, Hellwig K, Hillert J, Houtchens M, Magyari M, Montgomery S, Simoni M, Stenager E, Thompson H, Tulek Z, Marhardt K, Nappi RE
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning. Eur J Contracept Reprod Health Care. 2025 Apr; 30(2):59-73.
Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning.
Houtchens MK, Manieri MC, Mahlanza TD, Pol-Patil J, Klawiter EC, Solomon AJ, Lathi E, Katz J, Ionete C, Morales IB, Severson C, Zurawski J, Stankiewicz JM, Cabot A, Sadovnick AD
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS. Neurol Clin Pract. 2025 Apr; 15(2):e200425.
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.
Menopause in multiple sclerosis: therapeutic considerations. J Neurol. 2014 Jul; 261(7):1257-68.
Menopause in multiple sclerosis: therapeutic considerations.
Rose M, Hsu S, Balan A, Anderson A, Houtchens M, Bove R
Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study (P4-6.014). Neurology. 2024 Apr 09; 102(7_supplement_1):6314.
Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study (P4-6.014).
Zurawski J, Tauhid S, Healy BC, Chu R, Houtchens MK, Jalkh Y, Khalil S, Quattrucci M, Mateen FJ, Napoli S, Rizvi S, Singhal T, Bakshi R
Cladribine Is Associated With Stable Cortical Gray Matter Lesion Burden in Multiple Sclerosis: A 7T MRI Study. J Neuroimaging. 2025 Mar-Apr; 35(2):e70032.
Cladribine Is Associated With Stable Cortical Gray Matter Lesion Burden in Multiple Sclerosis: A 7T MRI Study.
Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.
Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, Weiner HL, Ceccarelli A
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport. 2014 Oct 01; 25(14):1156-61.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G, Lu E, McElrath TF, Smyth P, Tremlett H, Sadovnick AD
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol. 2014 Dec; 124(6):1157-1168.
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.
Access to Preventive Health Care in Severely Disabled Women with Multiple Sclerosis. Int J MS Care. 2015 Jul-Aug; 17(4):200-5.
Access to Preventive Health Care in Severely Disabled Women with Multiple Sclerosis.
Bove R, McHenry A, Hellwig K, Houtchens M, Razaz N, Smyth P, Tremlett H, Sadovnick AD, Rintell D
Multiple sclerosis in men: management considerations. J Neurol. 2016 Jul; 263(7):1263-73.
Multiple sclerosis in men: management considerations.
Zapata LB, Oduyebo T, Whiteman MK, Houtchens MK, Marchbanks PA, Curtis KM
Contraceptive use among women with multiple sclerosis: a systematic review. Contraception. 2016 12; 94(6):612-620.
Contraceptive use among women with multiple sclerosis: a systematic review.
Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana FJ, Chitnis T, Weiner HL, Healy BC, Bakshi R
The International journal of neuroscience
Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. Int J Neurosci. 2017 Nov; 127(11):971-980.
Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, Sperling RA, Khoury SJ, Guttmann CR, Weiner HL
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler. 2007 Sep; 13(8):1004-10.
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
Houtchens MK, Zapata LB, Curtis KM, Whiteman MK
Contraception for women with multiple sclerosis: Guidance for healthcare providers. Mult Scler. 2017 05; 23(6):757-764.
Contraception for women with multiple sclerosis: Guidance for healthcare providers.
Rose JW, Welsh CT, Hill KE, Houtchens MK, Fujinami RS, Townsend JJ
Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis. J Neuroimmunol. 1999 Jun 01; 97(1-2):110-8.
Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis.
Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, Weinstock-Guttman B, Guttmann CR, Bakshi R
Thalamic atrophy and cognition in multiple sclerosis. Neurology. 2007 Sep 18; 69(12):1213-23.
Thalamic atrophy and cognition in multiple sclerosis.
Saad A, Tuli S, Ali EN, Houtchens M, Delalle I, Kesari S
Pilocytic astrocytoma of the spinal cord in an adult. J Neurooncol. 2008 Jun; 88(2):189-91.
Pilocytic astrocytoma of the spinal cord in an adult.
Lee JW, Houtchens M, Hochberg F, Price B, M L, Cunnane M, Pfannl R, MacCollin M
Glioblastoma multiforme presenting as bilateral internal auditory canal tumors. J Neurol. 2006 Apr; 253(4):522-4.
Glioblastoma multiforme presenting as bilateral internal auditory canal tumors.
Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging. 2011 Apr; 21(2):e50-6.
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.
Klein JP, Arora A, Neema M, Healy BC, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Stankiewicz JM, Cohen AB, Buckle GJ, Houtchens MK, Ceccarelli A, Dell'Oglio E, Guttmann CR, Alsop DC, Hackney DB, Bakshi R
AJNR. American journal of neuroradiology
A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol. 2011 Jun-Jul; 32(6):1138-42.
A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.
Baharnoori M, Mahajan R, Solomon IH, Pinkus G, Houtchens M
Fingolimod-Associated Intracerebral Lymphoproliferative Disorder. Am J Ther. 2019 Jul/Aug; 26(4):e481-e484.
Fingolimod-Associated Intracerebral Lymphoproliferative Disorder.
Pregnancy and multiple sclerosis. Semin Neurol. 2007 Nov; 27(5):434-41.
Reproductive Issues in MS. Semin Neurol. 2017 12; 37(6):632-642.